Trial Profile
Morning Hypertension and Patient Self-monitoring
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2014
Price :
$35
*
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 22 Sep 2014 New trial record